Novel Issues in the Treatment of Heart Failure, Based on the European Society of Cardiology (ESC) 2023 Congress
International Journal of Cardiovascular Practice · 2023
DOI: 10.5812/intjcardiovascpract-142347 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiovascular Practice, 2023. Verfasst von Sepideh Jafari Naeini. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Context
Despite advances in the treatment of heart failure, mortality and morbidity remain high. Novel medical and surgical treatments have attempted to reduce the burden of disease. Evidence Acquisition: In this review, we discussed newly proposed strategies for the treatment of heart failure based on the recent European Society of Cardiology (ESC) congress.
Results
Recent advances in heart failure treatment may play a pivotal role in prognosis and lead to significant changes in guideline-based recommendations.
Conclusions
Recent trials have demonstrated the effectiveness of several adjuvant treatments for heart failure.
Zitieren
APA
Naeini, S. J. (2023). Novel Issues in the Treatment of Heart Failure, Based on the European Society of Cardiology (ESC) 2023 Congress. International Journal of Cardiovascular Practice. https://doi.org/10.5812/intjcardiovascpract-142347
Vancouver
Naeini SJ. Novel Issues in the Treatment of Heart Failure, Based on the European Society of Cardiology (ESC) 2023 Congress. International Journal of Cardiovascular Practice. 2023. doi:10.5812/intjcardiovascpract-142347
BibTeX
@article{Naeini2023,
author = {Naeini, Sepideh Jafari},
title = {Novel Issues in the Treatment of Heart Failure, Based on the European Society of Cardiology (ESC) 2023 Congress},
journal = {International Journal of Cardiovascular Practice},
year = {2023},
doi = {10.5812/intjcardiovascpract-142347}
}
EUVIMED